Delivery Order SPE2DB24D2012-SPE2DB25FBWPF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, reflects a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed the delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.89 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a brand-name diabetes medication. This firm fixed-price delivery order, awarded on August 13, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,138.88 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,342.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,958.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was awarded without set-aside designations through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,764.69 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 12, 2025, with completion targeted for August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, and represents a small-value pharmaceutical procurement within the company's...
- The Defense Logistics Agency awarded a $4,524.48 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens. This firm fixed-price, competitively awarded contract was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWPFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,370.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed-price delivery order, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, carries no set-aside designation and represents a competitively awarded transaction. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated capability to meet federal procurement requirements through open competition, with its contract portfolio spanning diabetes medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/1/25 |